Corona Remedies Limited IPO
BSE, NSEOffer Date Coming Soon
₹ NaN /N/A Shares
TBA
Open DateTBA
Close DateTBA
Allotment DateTBA
Listing DateCorona Remedies IPO Issue Details
- Issue Price ₹N/A per equity share
- Face Value ₹10 Per Equity Share
- Issue Price ₹800 Crores Offer for Sale
- Listing at BSE, NSE
- Lead Manager JM Financial Ltd
IIFL Capital Services Ltd
Kotak Mahindra Capital Co.Ltd
Kotak Mahindra Capital Co.Ltd. - Registrar Bigshare Services Pvt Ltd
Corona Remedies IPO Details
- Retail Portion 10%
Corona Remedies IPO Documents
Corona Remedies IPO Details
Corona Remedies Limited IPO is an upcoming book-building Mainboard IPO with a total issue size of ₹N/A crores. and a face value of ₹10 Per Equity Share each
The IPO dates, including opening and closing, are yet to be announced. The price band for the issue is also awaited
The allotment date and listing timeline will be updated once officially declared
JM Financial Ltd are acting as the Book Running Lead Managers for this IPO. , while Bigshare Services Pvt Ltd, is the registrar to the issue.
Corona Remedies Valuations
Corona Remedies Company Financials
| 31-Dec-24 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 870.21 | 830.58 | 595.02 |
| Revenue | 907.24 | 1,020.93 | 891.10 |
| Profit After Tax | 117.88 | 90.50 | 84.93 |
| Net Worth | 575.05 | 480.41 | 408.52 |
| Total Borrowing | 61.00 | 134.14 | 2.33 |
About Corona Remedies Company
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas.
The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas.
Presently, the company owns two manufacturing facilities located in the states of Gujarat.
As of December 31, 2024, the company had 88 R&D employees.
Corona Remedies - Promoter(s)
Dr. Kirtikumar Laxmidas Mehta
Niravkumar Kirtikumar Mehta
Ankur Kirtikumar Mehta
Pre Issue Share Holding : N/A%
Post Issue Share Holding : N/A%
Corona Remedies IPO - Issue Objectives
Contact Details
Corona Remedies
CORONA House, C – Mondeal Business Park, Near Gurudwara S. G. Highway, Thaltej, Ahmedabad, Gujarat, 380059
+91 79 4023 3000
Registrar Contact Details
Bigshare Services Pvt Ltd
+91-22-6263 8200
Corona Remedies IPO - FAQs
Ans. Corona Remedies Limited IPO is a Upcoming IPO. The issue is priced at ₹N/A per equity share. The minimum order quantity is N/A Shares. The IPO opens on TBA, and closes on TBA. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Corona Remedies Limited IPO opens on TBA and closes on TBA.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Corona Remedies Limited IPO is ₹800 Crores Offer for Sale.
Ans. The Corona Remedies Limited IPO price band is set between ₹N/A per equity share.
Ans. To apply for Corona Remedies Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Corona Remedies Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Corona Remedies Limited IPO is TBA.
Ans. The Corona Remedies Limited IPO will be listed on TBA.
Ans. Follow the steps to check the Corona Remedies Limited IPO allotment status online.
